This is the authors' abstract. We don't add key points for this paper.
Recently, Liu et al 1 and Kralovics et al 2 reported in this journal the possible diagnostic value of some biologic markers in chronic myeloproliferative disorders such as polycythemia vera (PV) and essential thrombocythemia (ET). Briefly, they described a strong correlation between endogenous erythroid colony growth in the absence of added erythropoietin (Epo) and polycythemia rubra vera 1 (PRV-1) expression in PV patients.
No takes yet. Share an insight, caveat, or question.
Florensa et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: